FI863192A0 - Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin. - Google Patents

Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin.

Info

Publication number
FI863192A0
FI863192A0 FI863192A FI863192A FI863192A0 FI 863192 A0 FI863192 A0 FI 863192A0 FI 863192 A FI863192 A FI 863192A FI 863192 A FI863192 A FI 863192A FI 863192 A0 FI863192 A0 FI 863192A0
Authority
FI
Finland
Prior art keywords
vitaminer
mediciner
intramuskulaer
injektering
preparat
Prior art date
Application number
FI863192A
Other languages
English (en)
Finnish (fi)
Other versions
FI863192A (fi
Inventor
Faruk Hadziselimovic
Original Assignee
Mepha Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ag filed Critical Mepha Ag
Publication of FI863192A publication Critical patent/FI863192A/fi
Publication of FI863192A0 publication Critical patent/FI863192A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI863192A 1984-12-07 1986-08-05 Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin. FI863192A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH586084 1984-12-07
PCT/CH1985/000172 WO1986003413A1 (en) 1984-12-07 1985-12-06 Preparations for the intramuscular injection of drugs, vitamins or vaccines

Publications (2)

Publication Number Publication Date
FI863192A FI863192A (fi) 1986-08-05
FI863192A0 true FI863192A0 (fi) 1986-08-05

Family

ID=4300514

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863192A FI863192A0 (fi) 1984-12-07 1986-08-05 Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin.

Country Status (9)

Country Link
EP (1) EP0204737B1 (da)
KR (1) KR870700024A (da)
AT (1) ATE74523T1 (da)
AU (1) AU5198686A (da)
DE (1) DE3585835D1 (da)
DK (1) DK365786D0 (da)
FI (1) FI863192A0 (da)
NO (1) NO863082L (da)
WO (1) WO1986003413A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
NO20014746D0 (no) 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
WO2006012700A1 (en) * 2004-08-04 2006-02-09 Team Health Pty Ltd Method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1023821A (fr) * 1950-04-21 1953-03-24 Solution stable de gluconate de calcium et procédé pour sa préparation
DE1007022B (de) * 1953-06-02 1957-04-25 Sandoz Ag Verfahren zur Verbesserung der Haltbarkeit und Loeslichkeit von Antihistamin-Praeparaten
DE1062389B (de) * 1958-02-11 1959-07-30 Wander Ag Dr A Verfahren zur Herstellung von sterilen, Kalziumsalze enthaltenden Vitamin-D-Loesungen
US4081527A (en) * 1976-12-07 1978-03-28 Pfizer Inc. Chlortetracycline compositions

Also Published As

Publication number Publication date
DK365786A (da) 1986-07-31
EP0204737B1 (de) 1992-04-08
WO1986003413A1 (en) 1986-06-19
KR870700024A (ko) 1987-02-28
AU5198686A (en) 1986-07-01
EP0204737A1 (de) 1986-12-17
ATE74523T1 (de) 1992-04-15
DK365786D0 (da) 1986-07-31
DE3585835D1 (de) 1992-05-14
FI863192A (fi) 1986-08-05
NO863082D0 (no) 1986-07-30
NO863082L (no) 1986-07-30

Similar Documents

Publication Publication Date Title
ES2061094T3 (es) Un procedimiento para la obtencion de una formulacion para disminuir el deseo imperioso de alcohol (craving) en el tratamiento del alcoholismo cronico.
ES2143539T3 (es) Uso de un agente fotosensibilizador.
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
DK0412149T3 (da) Anvendelse af IL-7 til tilvejebringelse af lægemidler til stimulering af blodpladeproduktion
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
ES2069582T3 (es) Nucleosidos terapeuticos.
ES2074124T5 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
FI935844A0 (fi) En doseringsform foer foerdroejd befriande av ett laekemedel
CY1110376T1 (el) Χρηση μιας συνθεσης που περιλαμβανει φορμοτερολη και βουδεσονιδη για την προληψη απο ή τη θεραπευτικη αντιμετωπιση μιας οξειας καταστασης ασθματος
NO863620D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
AR029174A1 (es) Derivados de espirooxindol, proceso para su preparacion, formulacion farmaceutica, y utilizacion de los derivados en la manufactura de medicamentos
PT90049A (pt) Forma de dosagem para administrar um medicamento para terapia humana
ES2042582T3 (es) Un procedimiento para preparar una composicion de sustancia que tiene una actividad fisiologica y nutricional util.
ATE74001T1 (de) Transdermales therapeutisches system.
DK1285667T3 (da) Farmaceutisk injicerbar oplösning af paracetamol og kombinationer af paracetamol med andre aktive bestanddele
HUP9900751A2 (hu) Parathormontartalmú stabil gyógyászati készítmény
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
SE8002715L (sv) Injicerbara lekemedel med inflammationshemmande verkan samt sett for framstellning derav
NL175882C (nl) Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
FI863192A (fi) Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin.
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ATE59550T1 (de) Chlorpheniramine therapie.
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MEPHA AG